Antidepressant dosage form
First Claim
Patent Images
1. A dosage form for delivering 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol having both controlled release and immediate release properties, the dosage form comprising:
- (a) a wall comprising at least in part a composition permeable to the passage of fluid, but not to 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol, which wall surrounds;
(b) a compartment;
(c) a drug composition in the compartment comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol;
(d) a displacement composition in the compartment comprising an osmotically active compound;
(e) an exit passageway in the dosage form for delivering the drug composition from the dosage form; and
(f) an external coat on the exterior of the wall that provides instant release of a drug for instant therapy, the drug comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol, and hydroxypropylmethylcellulose.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
120 Citations
3 Claims
-
1. A dosage form for delivering 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol having both controlled release and immediate release properties, the dosage form comprising:
-
(a) a wall comprising at least in part a composition permeable to the passage of fluid, but not to 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol, which wall surrounds;
(b) a compartment;
(c) a drug composition in the compartment comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol;
(d) a displacement composition in the compartment comprising an osmotically active compound;
(e) an exit passageway in the dosage form for delivering the drug composition from the dosage form; and
(f) an external coat on the exterior of the wall that provides instant release of a drug for instant therapy, the drug comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol, and hydroxypropylmethylcellulose. - View Dependent Claims (2, 3)
-
Specification